Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Polycythemia Vera and TP53[original query] |
|---|
| Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood 2010 1 115 (14): 2882-90. Thoennissen Nils H, Krug Utz O, Lee Dhong Hyun Tony, Kawamata Norihiko, Iwanski Gabriela B, Lasho Terra, Weiss Tamara, Nowak Daniel, Koren-Michowitz Maya, Kato Motohiro, Sanada Masashi, Shih Lee-Yung, Nagler Arnon, Raynaud Sophie D, Müller-Tidow Carsten, Mesa Ruben, Haferlach Torsten, Gilliland D Gary, Tefferi Ayalew, Ogawa Seishi, Koeffler H Phill |
| Bone marrow findings in blast phase of polycythemia vera. Annals of hematology 2017 12 97 (3): 425-434. Hidalgo López Juliana E, Carballo-Zarate Adrian, Verstovsek Srdan, Wang Sa A, Hu Shimin, Li Shaoying, Xu Jie, Zuo Wenli, Tang Zhenya, Yin C Cameron, Medeiros L Jeffrey, Bueso-Ramos Carlos E, Tang Guil |
| Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up. Annals of hematology 2017 11 97 (3): 443-451. Senín Alicia, Fernández-Rodríguez Concepción, Bellosillo Beatriz, Camacho Laura, Longarón Raquel, Angona Anna, Besses Carles, Álvarez-Larrán Alber |
| Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes, chromosomes & cancer 2019 7 59 (1): 30-39. Courtier Frédéric, Garnier Séverine, Carbuccia Nadine, Guille Arnaud, Adélaide José, Chaffanet Max, Hirsch Pierre, Paz Damien Luque, Slama Bohrane, Vey Norbert, Ugo Valérie, Delhommeau François, Rey Jérome, Birnbaum Daniel, Murati An |
| The Temporal Sequence and the Differences in Somatic Mutation Acquisition Determines Clinical Behaviors of JAK2-Positive Myeloproliferative Neoplasms. Anticancer research 2019 Nov 39 (11): 6273-6282. Byun Ja Min, Song Seulki, Koh Youngil, Yoon Sung-Soo, Kim Daeyo |
| Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood advances 2020 8 4 (15): 3708-3715. Debureaux Pierre-Edouard, Cassinat Bruno, Soret-Dulphy Juliette, Mora Barbara, Verger Emmanuelle, Maslah Nabih, Plessier Aurelie, Rautou Pierre-Emmanuel, Ollivier-Hourman Isabelle, De Ledinghen Victor, Goria Odile, Bureau Christophe, Siracusa Claudia, Valla Dominique, Giraudier Stephane, Passamonti Francesco, Kiladjian Jean-Jacqu |
| Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin. Blood advances 2020 11 4 (22): 5735-5744. Marcellino Bridget K, Farnoud Noushin, Cassinat Bruno, Lu Min, Verger Emanuelle, McGovern Erin, Patel Minal, Medina-Martinez Juan, Levine Max Fine, Arango Ossa Juanes E, Zhou Yangyu, Kosiorek Heidi, Mehrotra Meenakshi, Houldsworth Jane, Dueck Amylou, Rossi Michael, Mascarenhas John, Kiladjian Jean-Jacques, Rampal Raajit K, Hoffman Rona |
| A case of a primary myelofibrosis with progression and related literature review of progression phase genetics. International journal of laboratory hematology 2021 7 43 Suppl 1 78-81. Chen Dong, Fuda Franklin, Weinberg Ol |
| Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
| Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 2021 (7): 781-789. Gangat Naseema, Guglielmelli Paola, Szuber Natasha, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Al-Kali Aref, Foran James M, Palmer Jeanne M, Alkhateeb Hassan, Elliott Michelle A, Hanson Curtis A, Pardanani Animesh, Mannelli Francesco, Vannucchi Alessandro M, Tefferi Ayal |
| Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. Cancers 2023 8 15 (15): . Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell, Francesca Guijarro, Marta Santaliestra, Ana Triguero, Dolors Colomer, Francisco Cervantes, Alberto Álvarez-Larr |
| [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (4): 276-283. X Yan, T J Qin, B Li, S Q Qu, L J Pan, F H Li, N N Liu, Z J Xiao, Z F |
- Page last reviewed:Feb 1, 2024
- Content source: